You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tuberculosis, immunotherapy, drug-susceptible

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tuberculosis, Human Immunodeficiency Virus Trial (Optimised rifamycin)

Not yet recruiting
  • Tuberculosis
  • Human Immunodeficiency Virus
  • Optimised rifamycin
  • (no location specified)
Oct 8, 2022

Tuberculosis, Pulmonary, HIV Trial in Port-au-Prince, Cape Town (Bedaquiline, Clofazimine, Pyrazinamide)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • HIV
  • Port-au-Prince, Haiti
  • +1 more
Nov 11, 2022

Pulmonary Tuberculoses, Other Specified Pulmonary Tuberculosis Trial in Cape Town (BTZ-043, Rifafour e-275®, Probe Drug

Completed
  • Pulmonary Tuberculoses
  • Other Specified Pulmonary Tuberculosis
  • Cape Town, South Africa
  • +1 more
Aug 9, 2022

Pulmonary Tuberculosis Trial in Beijing (WX-081, Bedaquiline, Standard treatment)

Recruiting
  • Pulmonary Tuberculosis
  • Beijing, Beijing, China
    Beijing Chest Hospital affiliated to Capital Medical University
Dec 14, 2021

Tuberculosis Trial (GSK3036656, Bedaquiline, Delamanid)

Recruiting
  • Tuberculosis
  • Cape Town, South Africa
    GSK Investigational Site
Jan 24, 2023

HIV/AIDS, Tuberculosis, Pulmonary Trial in Durban (Biktarvy®, TLD- fixed-drug combination single tablet)

Recruiting
  • HIV/AIDS
  • Tuberculosis, Pulmonary
  • Biktarvy®
  • TLD- fixed-drug combination single tablet
  • Durban, KwaZulu-Natal, South Africa
    CAPRISA Springfield Clinical Research Site
Mar 14, 2022

MDR-TB, Immunotherapy Trial in Shanghai (V?2Vd2 T lymphocyte-based immunotherapy, Treatment regimens for MDR-TB)

Recruiting
  • MDR-TB
  • Immunotherapy
  • Vγ2Vδ2 T lymphocyte-based immunotherapy
  • Treatment regimens for MDR-TB
  • Shanghai, China
  • +1 more
Aug 8, 2022

Pulmonary TB Trial in South Africa (Delamanid + Bedaquiline + OPC-167832 10 mg, Delamanid + Bedaquiline + OPC-167832 30 mg,

Recruiting
  • Pulmonary TB
  • Delamanid + Bedaquiline + OPC-167832 10 mg
  • +3 more
  • Tembisa, Gauteng, South Africa
  • +7 more
Jun 30, 2022

Tuberculosis Trial in Groningen (Amikacin Inhalation Dry Powder, Amikacin Injectable Product)

Recruiting
  • Tuberculosis
  • Amikacin Inhalation Dry Powder
  • Amikacin Injectable Product
  • Groningen, Netherlands
    University Medical Center Groningen
Apr 30, 2021

Tuberculosis, Pulmonary Trial in South Africa, Tanzania (H56:IC31, Placebo)

Recruiting
  • Tuberculosis, Pulmonary
  • H56:IC31
  • Placebo
  • Bellville, Cape Town, South Africa
  • +5 more
Sep 27, 2021

Tuberculosis, Pulmonary Trial in Godoy Cruz (RUTI® Vaccine, Placebo)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • RUTI® Vaccine
  • Placebo
  • Godoy Cruz, Mendoza, Argentina
    Hospital José Nestor Lencinas
Jul 26, 2022

Tuberculosis, Pulmonary Trial in Kaohsiung, Taipei, Taoyuan City (4-month rifapentine-based regimen)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • 4-month rifapentine-based regimen
  • Kaohsiung, Taiwan
  • +3 more
Apr 22, 2021

Tuberculosis Trial in Worldwide (Rifampin)

Not yet recruiting
  • Tuberculosis
  • Groningen, Netherlands
  • +4 more
Feb 22, 2021

Pulmonary TB Trial in Islamabad (New management mode)

Recruiting
  • Pulmonary TB
  • New management mode
  • Islamabad, Islammabd, Pakistan
  • +1 more
Nov 30, 2020

Rifampicin Susceptible Pulmonary Tuberculosis Trial in Cape Town (RESP301, HRZE)

Not yet recruiting
  • Rifampicin Susceptible Pulmonary Tuberculosis
  • Cape Town, Bellville, South Africa
    TASK Clinical Research Centre
Sep 11, 2023

Tuberculosis, Pulmonary Trial in Houston (Azacitidine Injection)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • Azacitidine Injection
  • Houston, Texas
    Harris Health System - Ben Taub Hospital
Sep 1, 2022

Tuberculosis, Pulmonary Trial in Cape Town (Sanfetrinem Cilexetil, Amoxicillin/clavulanic acid, Rifampicin)

Recruiting
  • Tuberculosis, Pulmonary
  • Sanfetrinem Cilexetil
  • +2 more
  • Cape Town, Western Cape, South Africa
    TASK Clinical Research Centre
May 19, 2022

Tuberculosis, Pulmonary Trial (Sitafloxacin, SMZ/TMP, Rifampin)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • (no location specified)
Jul 7, 2022

Tuberculosis Trial in Bellville 7530, Mowbray, Johannesburg (H56:IC31, Placebo)

Completed
Has Results
  • Tuberculosis
  • H56:IC31
  • Placebo
  • Bellville 7530, Cape Town, South Africa
  • +2 more
Oct 28, 2019

Malignant Solid Tumor Trial in Shanghai (Infusion of iNKT cells)

Completed
  • Malignant Solid Tumor
  • Infusion of iNKT cells
  • Shanghai, China
    Shanghai Public Health Clinical Center, Fudan University
May 6, 2022

Drug-resistant Tuberculosis, HIV Coinfection, Cost-Benefit Analysis Trial in Cape Town (Targeted next-generation sequencing)

Not yet recruiting
  • Drug-resistant Tuberculosis
  • +2 more
  • Targeted next-generation sequencing
  • Cape Town, South Africa
    South African National Health Laboratory Service
Sep 23, 2022

Tuberculosis, Multidrug Resistant Tuberculosis Trial in Paris (Tedizolid arm (SIVEXTRO®), Linezolid arm (ZYVOXID®), Standard

Not yet recruiting
  • Tuberculosis
  • Multidrug Resistant Tuberculosis
  • Tedizolid arm (SIVEXTRO®)
  • +2 more
  • Paris, France
    Bacteriology department- Hôpital Saint-Antoine
Sep 6, 2022

Tuberculosis, Pulmonary Trial (Cephalexin, Amoxicillin-Clavulanate 500 Mg-125 Mg Oral Tablet, Standard of care treatment of

Not yet recruiting
  • Tuberculosis, Pulmonary
  • (no location specified)
Dec 15, 2022

Pharmacometrics to Advance Novel Regimens for Drug-resistant

Recruiting
  • Multi-drug Resistant Tuberculosis
    • Almaty, Kazakhstan
    • +6 more
    Nov 1, 2022

    Tuberculosis, Pulmonary Trial in Linköping (rifampicin, pyrazinamide, HRZE)

    Recruiting
    • Tuberculosis, Pulmonary
    • Linköping, Sweden
      Linköping University Hospital
    Aug 19, 2021